Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Gibson, Joanne H ^a,b,e   Slobedman, Barry ^c   KN, Harikrishnan ^d   Williamson, Sarah L ^a   Minchenko, Dimitri ^a   El Osta, Assam ^d   Stern, Joshua L ^c   Christodoulou, John ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; COMPLEMENTARY DNA; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT 1; DYNAMIN I; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; UNCLASSIFIED DRUG; CLU PROTEIN, HUMAN; MECP2 PROTEIN, HUMAN; NERVE PROTEIN;

ADULT; ARTICLE; BRAIN TISSUE; CHILD; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FRONTAL CORTEX; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETT SYNDROME; RNA INTERFERENCE; ADOLESCENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CLUSTERIN; DYNAMIN I; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RETT SYNDROME; RNA, MESSENGER; YOUNG ADULT;

EID: 77951243470     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-53     Document Type: Article

References (51)

1. Williamson SL, Christodoulou J. Rett syndrome: new clinical and molecular insights. Eur J Hum Genet 2006, 14:896-903. 10.1038/sj.ejhg.5201580, 16865103.
2. Bauman M, Kemper T, Arin D. Microscopic observations of the brain in Rett syndrome. Neuropediatr 1995, 26:105-108.
3. Witt Engerstrom I, Kerr A. Workshop on autonomic function in Rett syndrome. Brain Dev 1998, 323-326.
4. Armstrong D, Dunn JK, Antalffy B, Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropath Exp Neurol 1995, 54:195-201. 10.1097/00005072-199503000-00006, 7876888.
5. Belichenko P, Oldfors A, Hagberg B, Dahlstrom A. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994, 5:1509-1513. 10.1097/00001756-199407000-00025, 7948850.
6. Amir RE, Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet 1999, 23:185-188. 10.1038/13810, 10508514.
7. Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, Zoghbi HY. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci (USA) 2005, 102:17551-17558.
8. Horike SI, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005, 37:31-40. 10.1038/ng1570, 15608638.
9. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229. 10.1126/science.1153252, 2443785, 18511691.
10. Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M, Sperner J, Fryns JP, Schwinger E, Gecz J, Ropers HH, Kalscheuer VM. Mutations in the X-Linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 2004, 75:1149-1154. 10.1086/426460, 1182152, 15499549.
11. Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, Archer H, Evans J, Clarke A, Pelka GJ, Tam PP, Watson C, Lahooti H, Ellaway CJ, Bennetts B, Leonard H, Gecz J. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 2004, 75:1079-1093. 10.1086/426462, 1182143, 15492925.
12. Scala E, Ariani F, Mari F, Caselli R, Pescucci C, Longo I, Meloni I, Giachino D, Bruttini M, Hayek G, Zappella M, Renieri A. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 2005, 42:103-107. 10.1136/jmg.2004.026237, 1735977, 15689447.
13. Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A, Pollazzon M, Buoni S, Spiga O, Ricciardi S, Meloni I, Longo I, mari F, Broccoli V, Zappella M, Renieri A. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008, 83:89-93. 10.1016/j.ajhg.2008.05.015, 2443837, 18571142.
14. Aber K, Nori P, MacDonald S, Bibat G, Jarrar M, Kaufmann WE. Methyl-CpG-binding protein 2 is localised in the postsynaptic compartment: an immunochemical study of subcellular fractions. Neurosci 2003, 116:77-80.
15. Colantuoni C, Jeon O, Hyder K, Chenchik A, Khimani A, Narayanan V, Hoffman EP, Kaufmann WE, Naidu S, Pevsner J. Gene expression profiling in postmortem Rett syndrome brain: differential expression and patient classification. Neurobiol Dis 2001, 8:847-865. 10.1006/nbdi.2001.0428, 11592853.
16. Ballestar E, Ropero S, Alaminos M, Armstrong J, Setien F, Agrelo R, Fraga MF, Herranz M, Avila S, Pineda M, Monros E, Esteller M. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum Genet 2005, 116:91-104. 10.1007/s00439-004-1200-0, 15549394.
17. Delgado IJ, Kim DS, Thatcher KN, LaSalle JM, Veyver IB. Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients. BMC Med Genet 2006, 7:61. 10.1186/1471-2350-7-61, 1569822, 16859563.
18. Traynor J, Agarwal P, Lazzeroni L, Francke U. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Medical Genetics 2002, 3:12. 10.1186/1471-2350-3-12, 137585, 12418965.
19. Tudor M, Akbarian S, Chen RZ, Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci (USA) 2002, 99:15536-15541.
20. Nuber UA, Kriaucionis S, Roloff TC, Guy J, Selfridge J, Steinhoff C, Schulz R, Lipkowitz B, Ropers HH, Holmes MC, Bird A. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 2005, 14:2247-2256. 10.1093/hmg/ddi229, 16002417.
21. Kriaucionis S, Paterson A, Curtis J, Guy J, MacLeod N, Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Molec Cell Biol 2006, 26:5033-5042. 10.1128/MCB.01665-05, 1489175, 16782889.
22. Pelka GJ, Watson CM, Radziewic T, Hayward M, Lahooti H, Christodoulou J, Tam PP. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 2006, 129:887-898. 10.1093/brain/awl022, 16467389.
23. Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY. Clusterin inhibits apoptosis by interacting with activated Bax. Nature Cell Biol 2005, 7:909-915. 10.1038/ncb1291, 16113678.
24. Ruch A, Kurczynski TW, Velasco ME. Mitochondrial alterations in Rett syndrome. Pediatr Neurol 1989, 5:320-323. 10.1016/0887-8994(89)90027-1, 2803392.
25. Wakai S, Kameda K, Ishikawa Y, Miyamoto S, Nagaoka M, Okabe M, Minami R, Tachi N. Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities. Pediatr Neurol 1990, 6:339-343. 10.1016/0887-8994(90)90028-Y, 2242177.
26. Coker SB, Melnyk AR. Rett syndrome and mitochondrial enzyme deficiencies. J Child Neurol 1991, 6:164-166. 10.1177/088307389100600216, 1646255.
27. Cornford ME, Philippart M, Jacobs B, Scheibel AB, Vinters HV. Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain. J Child Neurol 1994, 9:424-431. 10.1177/088307389400900419, 7822737.
28. Sierra C, Vilaseca MA, Brandi N, Artuch R, Mira A, Nieto M, Pineda M. Oxidative stress in Rett syndrome. Brain Dev 2001, 23:S236-S239. 10.1016/S0387-7604(01)00369-2, 11738881.
29. Heilstedt HA, Shahbazian MD, Lee B. Infantile hypotonia as a presentation of Rett syndrome. Am J Med Genet 2002, 111:238-242. 10.1002/ajmg.10633, 12210319.
30. Peddada S, Yasui DH, LaSalle JM. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet 2006, 15:2003-2014. 10.1093/hmg/ddl124, 1931415, 16682435.
31. Finsterer J. Mitochondriopathies. Eur J Neurol 2004, 11:163-186. 10.1046/j.1351-5101.2003.00728.x, 15009163.
32. Sweitzer SM, Hinshaw JE. Dynamin undergoes a GTP-dependent conformational change causing vesiculation. Cell 1998, 93:1021-1029. 10.1016/S0092-8674(00)81207-6, 9635431.
33. Blue ME, Naidu S, Johnston MV. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 1999, 156:345-352. 10.1006/exnr.1999.7030, 10328941.
34. Asaka Y, Jugloff DGM, Zhang L, Eubanks JH, Fitzsimonds RM. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of of Rett syndrome. Neurobiol Dis 2006, 21:217-227. 10.1016/j.nbd.2005.07.005, 16087343.
35. Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147. 10.1126/science.1138389, 17289941.
36. Carroll RC, Beattie EC, Xia H, Luscher C, Altschuler Y, Nicoll RA, Malenka RC, von Zastrow M. Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl Acad Sci (USA) 1999, 96:14112-14117.
37. Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52:255-269. 10.1016/j.neuron.2006.09.037, 17046689.
38. DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM, Holtzman DM. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 2004, 41:193-202. 10.1016/S0896-6273(03)00850-X, 14741101.
39. McGeer P, Kawamata T, Walker D. Distribution of clusterin in Alzheimer brain tissue. Brain Res 1992, 579:337-341. 10.1016/0006-8993(92)90071-G, 1378350.
40. Sasaki K, Doh-ura K, Ironside J, Mabbott N, Iwaki T. Clusterin expression in follicular dendritic cells associated with prion protein accumulation. J Path 2006, 209:484-491. 10.1002/path.2009, 16767691.
41. Dragunow M, Preston K, Dodd J, Young D, Lawlor P, Christie D. Clusterin accumulates in dying neurons following status epilepticus. Brain Res Mol Brain Res 1995, 32:279-290. 10.1016/0169-328X(95)00088-A, 7500839.
42. Imhof A, Charnay Y, Vallet P, Aronow B, Kovari E, French LE, Bouras C, Giannakopoulos P. Sustained astrocytic clusterin expression improves remodeling after brain ischemia. Neurobiol Dis 2006, 22:274-283. 10.1016/j.nbd.2005.11.009, 16473512.
43. Nuutinen T, Suuronen T, Kyrylenko S, Huuskonen J, Salminen A. Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells. Neurochem Int 2005, 47:528-538. 10.1016/j.neuint.2005.07.007, 16157419.
44. Bretin S, Reibel S, Charrier E, Maus-Moatti M, Auvergnon N, Thevenoux A, Glowinski J, Rogemond V, Premont J, Honnorat J, Gauchy C. Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. Journal Compar Neurol 2005, 486:1-17.
45. Su KY, Chien WL, Fu WM, Yu IS, Huang HP, Huang PH, Lin SR, Shih JY, Lin YL, Hsueh YP, Yang PC, Lin SW. Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. J Neurosci 2007, 27:2513-2524. 10.1523/JNEUROSCI.4497-06.2007, 17344389.
46. Matarazzo V, Ronnett GV. Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency. Proc Natl Acad Sci (USA) 2004, 101:7763-7768.
47. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genet 2001, 29:365-371. 10.1038/ng1201-365, 11726920.
48. Gelder RNV, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of hetergenous cDNA. Proc Natl Acad Sci (USA) 1990, 87:1663-1667.
49. Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M, Coleman P. Analysis of gene expression in single live neurons. Proc Natl Acad Sci (USA) 1992, 89:3010-3014.
50. Williams A, Coakley J, Christodoulou J. Automated analysis of mitochondrial enzymes in cultured skin fibroblasts. Anal Biochem 1998, 259:176-180. 10.1006/abio.1998.2624, 9618194.
51. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Method Enzymol 1996, 264:484-509.